Most Recent
Sanofi loses challenge to Amgen patents for cholesterol-busting Repatha
Intellectual Property 2025-04-23 1:13 pm By Christine Caulfield

Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?